연구성과로 돌아가기

2023 연구성과 (27 / 285)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
Meeting Abstract The Impacts of Skeletal Muscle Mass and Quality on Kidney Recovery of Patients with AKI Receiving Continuous Renal Replacement Therapy Park, Jae Yoon; Paek, Jin hyuk; Jung, Jiyun; Lim, Jeong-Hoon; Kim, Yong Chul; Ban, Tae Hyun; Kim, Kipyo; Kim, Hyosang; Park, Woo Yeong Dongguk Univ, Ilsan Hosp, Goyang, Gyeonggi Do, South Korea; Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea; Kyungpook Natl Univ Hosp, Daegu, South Korea; Seoul Natl Univ Hosp, Seoul, South Korea; Catholic Univ Korea, Sch Med, Seoul, South Korea; Inha Univ, Sch Med, Incheon, South Korea; Asan Med Ctr, Seoul, South Korea JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY J AM SOC NEPHROL 1046-6673 1533-3450 34 11 SCIE UROLOGY & NEPHROLOGY 2023 10.3 4.4 0 English 2023 2023-11 바로가기 바로가기
Meeting Abstract ALCOHOL CONSUMPTION ACCELERATES HEPATIC MICROPLASTIC ACCUMULATION VIA IMPAIRED INTESTINAL MUCOSAL BARRIER Baek, Su-Min; Kim, Tae-Un; Yim, Jae-Hyuk; Kim, Woo Jun; Park, Jin-Kyu Kyungpook Natl Univ, Daegu, South Korea Kim, Woo/D-2733-2015 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS Park, JeongSu; Lee, Jin; Wang, Feng; Ma, Hwan; Lee, Yong-Sun; Lee, SangKyu; Yang, Yoon Mee; Yoo, Hwan-Soo; Han, Sang-Bae; Kim, Bumseok; Hong, Jin Tae; Roh, Yoon-Seok Chungbuk Natl Univ, Cheongju, South Korea; Univ Calif San Diego, La Jolla, CA USA; Natl Inst Food & Drug Safety Evaluat, Cheongju, South Korea; Kyungpook Natl Univ, Daegu, South Korea; Kangwon Natl Univ, Chunchon, South Korea; Jeonbuk Natl Univ, Biosafety Res Inst, Iksan 54596, South Korea; Jeonbuk Natl Univ, Coll Vet Med, Iksan 54596, South Korea Yoo, Hwan/N-4449-2018; Kim, Soo-Yeon/ADR-9663-2022; Yang, YoonMee/NQF-2987-2025 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆ Lee, Yu Rim; Woo, Hyun Young; Park, Jung Gil; Kang, Min Kyu; Song, Jeongeun; Kuk, Jang Byoung; Kweon, Young-Oh; Tak, Won Young; Jang, Se Young; Park, Soo Young; Lee, Chang-Hyeong; Kim, Byung Seok; Hwang, Jaeseok; Chung, Woo Jin; Heo, Jeong; Hur, Keun Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Pusan Natl Univ, Busan, South Korea; Yeungnam Univ, Coll Med, Gyongsan, South Korea; Daegu Catholic Univ, Sch Med, Gyongsan, South Korea; Keimyung Univ, Sch Med, Daegu, South Korea; Kyungpook Natl Univ, Daegu, South Korea; Kyungpook Natl Univ, Coll Med, Daegu, South Korea; Keimyung Univ, Daegu, South Korea; Pusan Natl Univ, Dept Internal Med, Coll Med, Busan, South Korea Kim, Seul Kee/A-6076-2015; Heo, Jeong/MHQ-1390-2025; Hur, Keun/G-9513-2011; Park, Jung/AAK-5167-2020; Kang, Min/U-8050-2018 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract ATTENUATED LIVER TUMORIGENESIS IN FEMALE MICE IS ATTRIBUTED TO CONSERVED POLA1 EXPRESSION BY SMP30 Baek, Su-Min; Park, Jin-Kyu Kyungpook Natl Univ, Daegu, South Korea HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR Yim, Hyung Joon; Kang, Seong Hee; Jung, Young Kul; Ahn, Sang Hoon; Kim, Won; Yang, Jin Mo; Jang, Jae Young; Cho, Yong Kyun; Kim, Yoon Jun; Kim, Dong Joon; Kweon, Young-Oh; Hong, Gun Young; Sohn, Joo Hyun; Lee, Jin-Woo; Park, Sung Jae; Young, Yim Sun; Shin, Seung Kak; Kim, Ji Hoon; Seo, Yeon Seok; Park, Jin Kyung; Um, Soonho Korea Univ, Ansan Hosp, Ansan, South Korea; Severance Hosp, Seoul, South Korea; Seoul Natl Univ, Seoul, South Korea; Catholic Univ Korea, Seoul, South Korea; Soonchunhyang Univ, Coll Med, Asan, South Korea; Sungkyunkwan Univ, Sch Med, Seoul, South Korea; Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; Hallym Univ, Inst Liver & Digest Dis, Coll Med, Chunchon 24252, South Korea; Kyungpook Natl Univ, Coll Med, Daegu, South Korea; Kwangju Christian Hosp, Kwangju, South Korea; Hanyang Univ, Coll Med, Seoul, South Korea; Inha Univ, Incheon, South Korea; Inje Univ, Coll Med, Gimhae, South Korea; Korea Univ Hosp, Seoul, South Korea; Gachon Univ, Gil Med Ctr, Incheon, South Korea; Korea Univ, Korea Univ Anam Hosp, Coll Med, Seoul, South Korea; Ildong Pharmaceut Co, Seoul, South Korea; Korea Univ, Coll Med, Seoul, South Korea Kim, Young/T-8521-2019; Kim, Eun Young/JCE-3602-2023; Kim, Ji/AAN-5655-2021; Kim, Won/H-6940-2019; Kim, Yoon/J-2746-2012 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Schwarz, Kathleen B.; Bezerra, Jorge A.; Choe, Byung Ho; Lin, Chuan-Hao; Abramov, Frida; Wang, Hongyuan; Liu, Yang; Flaherty, John F.; Pacurar, Daniela; Kim, Kyung Mo; Khaertynova, Ilsiyar; Shalimar; Wu, Jia-Feng; Tandon, Manish; Rosenthal, Philip; Morozov, Viacheslav; Sokal, Etienne M.; Chang, Mei Hwei Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA; Univ Texas Southwestern Med Ctr, Dallas, TX USA; Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea; Childrens Hosp Los Angeles, Los Angeles, CA USA; Gilead Sci Inc, Foster City, CA USA; Carol Davila Univ Med & Pharm, Bucharest, Romania; Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea; Kazan State Med Univ, Kazan, Russia; All India Inst Med Sci, Delhi, India; Natl Taiwan Univ Hosp, Taipei, Taiwan; MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India; Univ Calif San Francisco, San Francisco, CA 94143 USA; Hepatolog Med Co, Samara, Russia; Clin Univ St Luc, Brussels, Belgium; Natl Taiwan Univ, Taipei, Taiwan; Children Hosp, Taipei, Taiwan Wu, Jiafeng/KZU-6709-2024; Pacurar, Daniela/IYS-1131-2023; Choe, Byung-Ho/KSM-6251-2024; Lin, Chuan-Hao/AAH-6563-2019; wang, hongyuan/JWP-2279-2024 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 3 English 2023 2023-10 바로가기 바로가기
Meeting Abstract HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY Lee, Yu Rim; Woo, Hyun Young; Park, Jung Gil; Kang, Min Kyu; Song, Jeongeun; Jang, Byoung-Kuk; Kweon, Young-Oh; Tak, Won Young; Jang, Se Young; Park, Soo Young; Hur, Keun; Lee, Chang-Hyeong; Kim, Byung Seok; Hwang, Jaeseok; Chung, Woo Jin; Heo, Jeong; Heo, Nae-Yun; Park, Seung Ha; Yoon, Junsik; Baek, Yang Hyun Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Pusan Natl Univ, Busan, South Korea; Yeungnam Univ, Coll Med, Gyongsan, South Korea; Daegu Catholic Univ, Sch Med, Daegu, South Korea; Keimyung Univ, Sch Med, Daegu, South Korea; Kyungpook Natl Univ, Daegu, South Korea; Kyungpook Natl Univ, Coll Med, Daegu, South Korea; Keimyung Univ, Daegu, South Korea; Pusan Natl Univ, Dept Internal Med, Coll Med, Busan, South Korea; Inje Univ, Haeundae Paik Hosp, Gimhae, South Korea; Busan Paik Hosp, Busan, South Korea; Dong A Univ, Coll Med, Busan, South Korea Heo, Nae-Yun/LUY-9667-2024; Heo, Jeong/MHQ-1390-2025; Kim, Seul Kee/A-6076-2015; Park, Jung/AAK-5167-2020; Kang, Min/U-8050-2018; Hur, Keun/G-9513-2011 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY Lim, Seng Gee; Gadano, Adrian; Stepanova, Tatyana; Diaconescu, Gheorghe Iulian; Fujiyama, Shigetoshi; Heo, Jeong; Kim, Ju Hyun; Kweon, Young Oh; Rizzardini, Giuliano; Idriz, Nevin; Gankina, Natalia; Kurosaki, Masayuki; Mohamed, Rosmawati; Piratvisuth, Teerha; Yuen, Man-Fung; Cremer, Ji Won; Elston, Robert; Quinn, Geoff; Paff, Melanie; Bouquet, Jerome; Lukic, Tamara; Theodore, Dickens Natl Univ Hlth Syst, Singapore, Singapore; Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; Modern Med Clin, Traralgon, Australia; Spitalul Clin Boli Infectioase Si Pneumoftiziol V, Craiova, Romania; Kumamoto Shinto Gen Hosp, Kumamoto, Japan; Pusan Natl Univ, Dept Internal Med, Coll Med, Busan, South Korea; Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; Gachon Univ, Gil Med Ctr, Incheon, South Korea; Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Asst Fatebenefratelli Sacco, Milan, Italy; Univ Med & Hosp Act Treatment Sofiamed, Sofia, Bulgaria; Krasnojarsk Reg Ctr AIDS Prevent, Krasnoyarsk, Russia; Musashino Red Cross Hosp, Tokyo, Japan; Univ Malaya, Med Ctr, Pusat Perubatan Univ Malaya, Kuala Lumpur, Malaysia; Nkc Inst Gastroenterol & Hepatol, Songkhla, Thailand; Queen Mary Hosp, Li Ka Shing Fac Med, Sch Clin Med, Dept Med, Hong Kong, Peoples R China; Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China; GSK, Durham, NC USA; GSK, Stevenage, Herts, England; GSK, Collegeville, PA USA; GSK, San Francisco, CA USA; GSK, Dubai, U Arab Emirates LIM, Seng/AAD-9040-2020; Yuen, Richard Man Fung/C-4466-2009; Heo, Jeong/MHQ-1390-2025 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract LONG- TERM ACCUMULATIONS OF POLYSTYRENE NANOPLASTICS SPECIFICALLY ACTIVATE HEPATIC STELLATE CELLS Yim, Jae-Hyuk; Baek, Su-Min; Kim, Tae-Un; Kim, Woo Jun; Park, Jin-Kyu Kyungpook Natl Univ, Daegu, South Korea Kim, Woo/D-2733-2015 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Article Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis Background: Comparative outcomes of HBV-infected compensated cirrhosis with low-level viremia (LLV) versus maintained virological response (MVR) are unclear. We conducted a large, multiethnic, multicenter study to examine the natural history of LLV versus MVR in compensated cirrhosis.Patients and Methods: We enrolled patients with HBV-infected compensated cirrhosis (n = 2316) from 19 hospitals in South Korea, Singapore, and Japan. We defined the LLV group as untreated patients with =1 detectable serum HBV-DNA (20-2000 IU/mL), Spontaneous-MVR group as untreated patients with spontaneously achieved MVR, and antiviral therapy (AVT)MVR group as patients achieving AVT-induced MVR. Study end points were HCC or hepatic decompensation.Results: The annual HCC incidence was 2.7/100 person-years (PYs), 2.6/ 100 PYs, and 3.3/100 PYs for LLV (n = 742), Spontaneous-MVR (n = 333), and AVT-MVR (n = 1241) groups, respectively (p = 0.81 between LLV vs. Spontaneous-MVR groups and p = 0.37 between LLV vs. AVT-MVR groups). Similarly, the annual decompensation incidence was 1.6/100 PYs, 1.9/100 PYs, and 1.6/100 PYs for LLV, Spontaneous-MVR, and AVT-MVR groups, respectively (p = 0.40 between LLV vs. Spontaneous-MVR groups and p = 0.83 between LLV vs. AVT-MVR groups). Multivariable analyses determined that HCC and decompensation risks in the LLV group were comparable to those with Spontaneous-MVR and AVT-MVR groups (all p > 0.05). Propensity score matching also reproduced similar results for HCC and decompensation risks (all p > 0.05 between LLV vs. Spontaneous-MVR groups and between LLV vs. AVT-MVR groups).Conclusions: Untreated LLV in HBV-infected compensated cirrhosis is not associated with increased risk of disease progression compared with Spontaneous-MVR and AVT-MVR. These data have important implications for practice and further research. Huang, Daniel Q. Q.; Tamaki, Nobuharu; Lee, Hyung Woong; Park, Soo Young; Lee, Yu Rim; Lee, Hye Won; Lim, Seng Gee; Lim, Tae Seop; Kurosaki, Masayuki; Marusawa, Hiroyuki; Mashiba, Toshie; Kondo, Masahiko; Uchida, Yasushi; Kobashi, Haruhiko; Furuta, Koichiro; Izumi, Namiki; Kim, Beom Kyung; Sinn, Dong Hyun Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore; Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; Matsuyama Red Cross Hosp, Ctr Liver Biliary Pancreat Dis, Matsuyama, Ehime, Japan; Japanese Red Cross Otsu Hosp, Dept Gastroenterol, Otsu, Shiga, Japan; Matsue Red Cross Hosp, Dept Gastroenterol, Matsue, Shimane, Japan; Japanese Red Cross Okayama Hosp, Dept Gastroenterol, Okayama, Okayama, Japan; Masuda Red Cross Hosp, Dept Gastroenterol, Masuda, Shimane, Japan; Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, 81 Irwon Ro, Seoul 06351, South Korea LIM, Seng/AAD-9040-2020; Lee, YuRim/ITU-1407-2023; Lee, Hye/D-9081-2016; Sinn, Dong/JAC-4247-2023; Huang, Daniel/LSJ-9214-2024; Kim, Kyung/I-5501-2015 57211508470; 36197581200; 57349302900; 57191674344; 57194094753; 57200110315; 57269602500; 56518959700; 35308923600; 6701365971; 6602815620; 36882270800; 7401607120; 7003583870; 57698134000; 7102192003; 35302925200; 23493891100 daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net; HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 77 5 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0.98 2025-06-25 9 11 CHRONIC HEPATITIS-B; HEPATOCELLULAR-CARCINOMA RISK; CORE-RELATED ANTIGEN; SURFACE-ANTIGEN; VIRUS DNA; INTEGRATION; SYSTEM Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Viremia; alanine aminotransferase; albumin; antivirus agent; aspartate aminotransferase; beta adrenergic receptor blocking agent; bilirubin; hepatitis B(e) antigen; hydroxymethylglutaryl coenzyme A reductase inhibitor; antivirus agent; virus DNA; adult; albumin blood level; anamnesis; antiviral therapy; Article; bilirubin blood level; Child Pugh score; compensated liver cirrhosis; controlled study; decompensated liver cirrhosis; diabetes mellitus; female; Fibrosis-4 Index; follow up; hepatitis B; human; human tissue; Japan; liver cell carcinoma; major clinical study; male; multicenter study; nonhuman; nuclear magnetic resonance imaging; outcome assessment; platelet count; propensity score; Singapore; South Korea; virus detection; x-ray computed tomography; clinical trial; genetics; Hepatitis B virus; liver cell carcinoma; liver cirrhosis; liver tumor; viremia English 2023 2023-05 10.1097/hep.0000000000000037 바로가기 바로가기 바로가기 바로가기
Article Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma Background Although temozolomide (TMZ) has been used as a standard adjuvant chemotherapeutic agent for primary glioblastoma (GBM), treating isocitrate dehydrogenase wild-type (IDH-wt) cases remains challenging due to intrinsic and acquired drug resistance. Therefore, elucidation of the molecular mechanisms of TMZ resistance is critical for its precision application.Methods We stratified 69 primary IDH-wt GBM patients into TMZ-resistant (n = 29) and sensitive (n = 40) groups, using TMZ screening of the corresponding patient-derived glioma stem-like cells (GSCs). Genomic and transcriptomic features were then examined to identify TMZ-associated molecular alterations. Subsequently, we developed a machine learning (ML) model to predict TMZ response from combined signatures. Moreover, TMZ response in multisector samples (52 tumor sectors from 18 cases) was evaluated to validate findings and investigate the impact of intra-tumoral heterogeneity on TMZ efficacy.Results In vitro TMZ sensitivity of patient-derived GSCs classified patients into groups with different survival outcomes (P = 1.12e-4 for progression-free survival (PFS) and 3.63e-4 for overall survival (OS)). Moreover, we found that elevated gene expression of EGR4, PAPPA, LRRC3, and ANXA3 was associated to intrinsic TMZ resistance. In addition, other features such as 5-aminolevulinic acid negative, mesenchymal/proneural expression subtypes, and hypermutation phenomena were prone to promote TMZ resistance. In contrast, concurrent copy-number-alteration in PTEN, EGFR, and CDKN2A/B was more frequent in TMZ-sensitive samples (Fisher's exact P = 0.0102), subsequently consolidated by multi-sector sequencing analyses. Integrating all features, we trained a ML tool to segregate TMZ-resistant and sensitive groups. Notably, our method segregated IDH-wt GBM patients from The Cancer Genome Atlas (TCGA) into two groups with divergent survival outcomes (P = 4.58e-4 for PFS and 3.66e-4 for OS). Furthermore, we showed a highly heterogeneous TMZ-response pattern within each GBM patient using in vitro TMZ screening and genomic characterization of multisector GSCs. Lastly, the prediction model that evaluates the TMZ efficacy for primary IDH-wt GBMs was developed into a webserver for public usage ().Conclusions We identified molecular characteristics associated to TMZ sensitivity, and illustrate the potential clinical value of a ML model trained from pharmacogenomic profiling of patient-derived GSC against IDH-wt GBMs. Nam, Yoonhee; Koo, Harim; Yang, Yingxi; Shin, Sang; Zhu, Zhihan; Kim, Donggeon; Cho, Hee Jin; Mu, Quanhua; Choi, Seung Won; Sa, Jason K.; Seo, Yun Jee; Kim, Yejin; Lee, Kyoungmin; Oh, Jeong-Woo; Kwon, Yong-Jun; Park, Woong-Yang; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Park, Chul-Kee; Lee, Hye Won; Yoon, Yeup; Wang, Jiguang Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea; Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang, South Korea; Natl Canc Ctr, Res Inst & Hosp, Dept Clin Res, Goyang, South Korea; Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; Kyungpook Natl Univ, Sch Convergence, Dept Biomed Convergence Sci & Technol, Daegu, South Korea; Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea; Columbia Univ, Dept Syst Biol, Program Math Genom, New York, NY USA; Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Seoul, South Korea; Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; Seoul Natl Univ Hosp, Seoul, South Korea; Natl Canc Ctr, Ctr Urol Canc, Dept Urol, Goyang, South Korea; Samsung Med Ctr, Dept Urol, Seoul, South Korea; Sungkyunkwan Univ, Dept Biopharmaceut Convergence, Seoul, South Korea; InnoHK, Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China; HKUST Shenzhen Hong Kong Collaborat Innovat Res In, Shenzhen, Peoples R China ; Mu, Quanhua/JKI-6568-2023; Park, Chul-Kee/J-5499-2012 57204287921; 57205687195; 57202532799; 56612613100; 58142794900; 57161227100; 55937716400; 55908407800; 57193525550; 56803454400; 56601550200; 57210413934; 57102132300; 57203033560; 35080680400; 7402229389; 10144905700; 57219637288; 57218516593; 56424318200; 57218088690; 7402126678; 53879035100 nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; GENOME MEDICINE GENOME MED 1756-994X 15 1 SCIE GENETICS & HEREDITY 2023 10.4 4.5 2.05 2025-06-25 13 13 Machine learning; Glioblastoma; Temozolomide; Pharmacogenomics; Cancer genomics; Intra-tumoral heterogeneity MALIGNANT GLIOMA; TEMOZOLOMIDE RESISTANCE; SELF-RENEWAL; EXPRESSION; MGMT; EVOLUTION; HETEROGENEITY; GROWTH; TUMORS Cancer genomics; Glioblastoma; Intra-tumoral heterogeneity; Machine learning; Pharmacogenomics; Temozolomide Brain Neoplasms; Drug Resistance, Neoplasm; Early Growth Response Transcription Factors; Glioblastoma; Glioma; Humans; Pharmacogenetics; Temozolomide; cyclin dependent kinase inhibitor 2A; cyclin dependent kinase inhibitor 2B; epidermal growth factor receptor; isocitrate dehydrogenase; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; pregnancy associated plasma protein A; temozolomide; early growth response factor; EGR4 protein, human; temozolomide; adult; aged; ANXA3 gene; Article; cancer chemotherapy; cell heterogeneity; cohort analysis; controlled study; copy number variation; drug efficacy; drug sensitivity; EGR4 gene; female; gene; gene expression; gene expression level; genomics; glioblastoma; glioma stem cell; human; human cell; in vitro study; LRRC3 gene; machine learning; major clinical study; male; overall survival; PAPPA gene; pharmacogenomics; progression free survival; RNA sequencing; somatic hypermutation; survival time; therapy resistance; transcriptomics; treatment response; whole exome sequencing; brain tumor; drug resistance; genetics; glioma; metabolism; pharmacogenetics English 2023 2023-03-13 10.1186/s13073-023-01165-8 바로가기 바로가기 바로가기 바로가기
Meeting Abstract PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES Lim, Young-Suk; Evans, Tom; Barnes, Eleanor; Mehta, Reena; Bussey, Louise; Anderson, Katie; Vardeu, Antonella; Brown, Anthony; Chen, Chi-Yi; Chuang, Wan-Long; Lo, Gin-Ho; Tak, Won Young; Tseng, Kuo-Chih Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, Seoul, South Korea; Univ Ulsan, Ctr Liver, Asan Med Ctr, Coll Med, Seoul, South Korea; Vaccitech, Clin Operat, Oxford, England; Univ Oxford, Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; Univ Oxford, Nuffield Dept Med, Oxford, England; Vaccitech Plc, Clin Operat, Oxford, England; Vaccitech Plc, Immunol Res, Oxford, England; Vaccitech, Res, Oxford, England; Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England; Chia Yi Christian Hosp, Chiayi, Taiwan; Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Sect, Dept Internal Med, Kaohsiung, Taiwan; E Da Hosp, Kaohsiung, Taiwan; Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Chiayi, Taiwan; Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Chiayi, Taiwan Mehta, Reena/LFU-3952-2024; Lim, Young-Suk/AFQ-5165-2022; Chuang, Wan-Long/C-9536-2009 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 77 5 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-05 바로가기 바로가기
Meeting Abstract PROPOSAL OF A NOVEL SEROLOGICAL ALGORITHM COMBINING A FIBROSIS INDEX BASED ON FOUR AND SERUM MAC-2 BINDING PROTEIN GLYCOSYLATION ISOMER FOR ADVANCED FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE Kang, Yeowool; Baek, Yang Hyun; Moon, Sang Yi; Jun, Dae Won; Jang, Se Young; Yoon, Ki Tae; Cho, Young Youn; Jo, Hoon Gil Dong A Univ, Busan, South Korea; Dong A Univ, Coll Med, Busan, South Korea; Hanyang Univ, Coll Med, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Pusan Natl Univ Hosp, Busan, South Korea; Chung Ang Univ Hosp, Seoul, South Korea; Wonkwang Univ Coll Med & Hosp, Iksan, South Korea Jun, Dae Won/O-4529-2017 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
Meeting Abstract PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY Yoon, Junsik; Hong, Ji Hoon; Park, Soo Young; Kim, Seung Up; Kim, Hwi Young; Kim, Ju Yeon; Hur, Moon Haeng; Park, Min Kyung; Bin Lee, Yun; Lee, Han Ah; Kim, Gi-Ae; Sinn, Dong Hyun; Park, Sung Jae; Lee, Youn-Jae; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Jeong-Hoon Inje Univ, Coll Med, Gimhae, South Korea; Seoul Natl Univ, Coll Med, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Daegu, South Korea; Yonsei Univ, Coll Med, Seoul, South Korea; Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Seoul Natl Univ Hosp, Seoul, South Korea; Kyung Hee Univ, Sch Med, Seoul, South Korea; Samsung Med Ctr, Seoul, South Korea; Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea Kim, Joo/X-7562-2019; Sinn, Dong/JAC-4247-2023; Yoon, Jung/J-5563-2012; Lee, Dong-Hyeon/AAM-3893-2021; Kim, Yoon/J-2746-2012; Kim, Sun/L-4239-2013; Lee, Yoon Jae/HGE-5712-2022; KIM, BYOUNG HYUCK/IRZ-5874-2023; Kim, Gi-Ae/AAZ-2547-2021 HEPATOLOGY HEPATOLOGY 0270-9139 1527-3350 78 SCIE GASTROENTEROLOGY & HEPATOLOGY 2023 13 4.5 0 English 2023 2023-10 바로가기 바로가기
페이지 이동:

논문 데이터 용어 설명

용어 설명
WoS Web of Science. Clarivate Analytics에서 제공하는 학술 데이터베이스입니다. 해당 논문이 WoS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
SCOPUS Elsevier에서 제공하는 세계 최대 규모의 초록 및 인용 데이터베이스입니다. 해당 논문이 SCOPUS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
Document Type 문헌의 유형을 나타냅니다. Article(원저), Review(리뷰), Proceeding Paper(학회논문), Editorial Material(편집자료), Letter(레터) 등으로 분류됩니다.
Title 논문의 제목입니다.
Abstract 논문의 초록(요약)입니다. 연구의 목적, 방법, 결과, 결론을 간략히 요약한 내용입니다.
Authors 논문의 저자 목록입니다. 공동 저자가 여러 명인 경우 세미콜론(;)으로 구분됩니다.
Affiliation 저자들의 소속 기관 정보입니다. 대학, 연구소, 기업 등 저자가 소속된 기관명이 표시됩니다.
ResearcherID (WoS) Web of Science의 고유 연구자 식별번호입니다. 동명이인을 구분하고 연구자의 업적을 정확하게 추적할 수 있습니다.
AuthorsID (SCOPUS) SCOPUS의 고유 저자 식별번호입니다. 연구자의 모든 출판물을 추적하고 관리하는 데 사용됩니다.
Journal 논문이 게재된 학술지의 정식 명칭입니다.
JCR Abbreviation Journal Citation Reports에서 사용하는 저널의 공식 약어입니다. 저널을 간략하게 표기할 때 사용됩니다.
ISSN International Standard Serial Number. 국제표준연속간행물번호로, 인쇄본 저널에 부여되는 고유 식별번호입니다.
eISSN Electronic ISSN. 전자 버전 저널에 부여되는 고유 식별번호입니다.
Volume 저널의 권(Volume) 번호입니다. 보통 연도별로 하나의 권이 부여됩니다.
Issue 저널의 호(Issue) 번호입니다. 한 권 내에서 여러 호로 나누어 출판되는 경우가 많습니다.
WoS Edition Web of Science의 에디션입니다. SCIE(Science Citation Index Expanded), SSCI(Social Sciences Citation Index), AHCI(Arts & Humanities Citation Index) 등으로 구분됩니다.
WoS Category Web of Science의 주제 분류 카테고리입니다. 저널과 논문이 속한 학문 분야를 나타냅니다.
JCR Year 해당 저널의 JCR(Journal Citation Reports) 지표가 산출된 연도입니다.
IF (Impact Factor) 저널 영향력 지수. 최근 2년간 발표된 논문이 해당 연도에 평균적으로 인용된 횟수를 나타냅니다. 저널의 학술적 영향력을 나타내는 대표적인 지표입니다.
JCR (%) 해당 카테고리에서 저널이 위치하는 상위 백분율입니다. 값이 낮을수록 우수한 저널임을 의미합니다 (예: 5%는 상위 5%를 의미).
FWCI Field-Weighted Citation Impact. 분야별 가중 인용 영향력 지수입니다. 논문이 받은 인용을 동일 분야, 동일 연도, 동일 문헌 유형의 평균과 비교한 값입니다. 1.0이 평균이며, 1.0보다 높으면 평균 이상의 인용을 받았음을 의미합니다.
FWCI UpdateDate FWCI 값이 마지막으로 업데이트된 날짜입니다. FWCI는 인용이 누적됨에 따라 주기적으로 업데이트됩니다.
WOS Citation Web of Science에서 집계된 해당 논문의 총 인용 횟수입니다.
SCOPUS Citation SCOPUS에서 집계된 해당 논문의 총 인용 횟수입니다.
Keywords (WoS) 저자가 논문에서 직접 지정한 키워드입니다. Web of Science에 등록된 저자 키워드 목록입니다.
KeywordsPlus (WoS) Web of Science에서 자동으로 추출한 추가 키워드입니다. 논문의 참고문헌 제목에서 자주 등장하는 단어들로 생성됩니다.
Keywords (SCOPUS) 저자가 논문에서 직접 지정한 키워드입니다. SCOPUS에 등록된 저자 키워드 목록입니다.
KeywordsPlus (SCOPUS) SCOPUS에서 자동으로 추출하거나 추가한 색인 키워드입니다.
Language 논문이 작성된 언어입니다. 대부분 English이며, 그 외 다양한 언어로 작성된 논문이 포함될 수 있습니다.
Publication Year 논문이 출판된 연도입니다.
Publication Date 논문의 정확한 출판 날짜입니다 (년-월-일 형식).
DOI Digital Object Identifier. 디지털 객체 식별자로, 논문을 고유하게 식별하는 영구적인 식별번호입니다. 이를 통해 논문의 온라인 위치를 찾을 수 있습니다.